Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: January 2025
Date of Filing: January 13, 2025
Headquarters: Herstal, Belgium
This filing serves to furnish a press release issued by the Company on January 13, 2025, as Exhibit 99.1. The information contained in the press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a cover sheet referencing an external press release and does not contain financial statements or quantitative data.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. The content is limited to the procedural submission of a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These details, if any, would be contained within the attached Exhibit 99.1 (Press Release), the text of which is not included in the provided input.
Investor Verification Checklist
- Review the full text of the press release attached as Exhibit 99.1 for specific operational or strategic updates.
- Verify the legal status of the information, noting it is "furnished" and not "filed" for liability purposes under the Exchange Act.
- Confirm the identity of the signatory, Michael McGarrity, Chief Executive Officer.
- Check subsequent filings for any financial data referenced in the press release.